STEP primarily targets projects in their development and manufacturing phases (technology readiness level from 4 to 9). By concentrating on these stages, it helps EU projects turn innovative ideas into real products ready for the market.
For a detailed perspective into implementing STEP, read the STEP guidance note about the STEP objectives, technology sectors and conditions.
This sector encompasses a wide array of technologies such as advanced semiconductors, artificial intelligence, robotics and quantum technologies. They are critical to tackling pressing global issues, including climate change, sustainable energy, connectivity and navigation.
Examples (indicative and non-exhaustive):
Microelectronics, including processors; photonic, including high-energy laser technologies; high frequency chips; semiconductor manufacturing equipment at very advanced node sizes; space-qualified semiconductor technologies.
AI algorithms; high performance computing (HPC); cloud and edge computing; data analytics technologies; computer vision, language processing, object recognition; privacy-preserving technologies (e.g., federated learning).
Quantum computing; quantum cryptography; quantum communications; Quantum Key Distribution (QKD); quantum sensing, including quantum gravimetry; quantum radar; quantum simulation; quantum imaging; quantum clocks; metrology; space-qualified quantum technologies.
Secure digital communications and connectivity, such as RAN (Radio Access Network) & Open RAN (Radio Access Network), and 5G and 6G; cyber security technologies, including cyber- surveillance, security and intrusion systems; digital forensics; internet of things and virtual reality; distributed ledger and digital identity technologies; guidance, navigation, and control technologies, including avionics and maritime positioning, and space-based PNT; satellite-based secure connectivity.
Electro-optical, radar, chemical, biological, radiation and distributed sensing; magnetometers, magnetic gradiometers; underwater electric field sensors; gravity meters, and gradiometers.
Autonomous habited and uninhabited vehicles (space, air, land, surface, and underwater), including swarming; robots and robot-controlled precision systems; exoskeletons; AI-enabled systems.
STEP accelerates the development and manufacturing of clean energy technologies, energy storage innovations, and decarbonisation solutions in the EU. Such innovations foster environmentally sustainable and cost-effective solutions for the green transition.
Examples drawing from the Net Zero Industry Act (indicative and non-exhaustive):
Solar photovoltaic technologies; solar thermal electric technologies; solar thermal technologies; other solar technologies.
Onshore wind technologies; offshore renewable technologies.
Battery technologies; energy storage technologies.
Heat pump technologies; geothermal energy technologies.
Electrolysers; hydrogen fuel cells; other hydrogen technologies.
Sustainable biogas technologies; sustainable bio-methane technologies.
Carbon capture technologies; carbon storage technologies.
Electricity grid technologies; electric charging technologies for transportation; technologies to digitalise the grid; other electricity grid technologies.
Nuclear fission energy technologies; nuclear fuel cycle technologies.
Sustainable alternative fuels technologies.
Hydropower technologies.
Osmotic energy technologies; ambient energy technologies, other than heat pumps; biomass technologies; landfill gas technologies; sewage treatment plant gas technologies; other renewable energy technologies.
Energy system-related energy efficiency technologies; heat grid technologies; other energy system-related energy efficiency technologies.
Renewable fuels of non-biological origin technologies.
Biotech climate and energy solutions.
Transformative industrial technologies for decarbonisation.
CO2 transport technologies; CO2 utilisation technologies.
Wind propulsion technologies; electric propulsion technologies.
Other nuclear technologies.
Other clean and resource efficient technologies (indicative, non-exhaustive).
Technologies for nanomaterials; smart materials; advanced ceramic materials; stealth materials; safe and sustainable by design materials; additive manufacturing; digital controlled micro-precision manufacturing and small-scale laser machining/welding; technologies for extraction; processing and recycling of critical raw materials and other components (e.g. catalyst, batteries), including hydrometallurgical extraction, bioleaching, nanotechnology-based filtration, electrochemical processing and black mass.
Purification and desalination technologies.
Technologies for the reuse and recycling of electronics (e-waste); circular bioeconomy technologies (e.g., for converting waste to valuable bio-based materials or energy).
Biotechnologies are key for making critical sectors like healthcare, farming, and the bioeconomy more modern and suited to the need of European citizens. A prominent area is the production of therapeutic proteins and other drugs through genetic engineering.
Examples (indicative and non-exhaustive):
Genomics; pharmacogenomics; gene probes; genetic engineering; DNA/RNA sequencing/synthesis/amplification; gene expression profiling, and use of antisense technology; large-scale DNA synthesis; new genomic techniques; gene drive.
Sequencing/synthesis/engineering/manufacturing of proteins and peptides (including large molecule hormones); improved delivery methods for large molecule drugs; proteomics; protein isolation and purification; signalling; identification of cell receptors; developing polyclonal products.
Cell/tissue culture; tissue engineering (including tissue scaffolds and biomedical engineering); cellular fusion; marker assisted breeding technologies; metabolic engineering; cell therapies; bioprinting of cells/replacement organs.
Fermentation using bioreactors; biorefining; bioprocessing; bioleaching; biopulping; biobleaching; biodesulphurisation; bioremediation; biosensing; biofiltration and phytoremediation; molecular aquaculture; protection and decontamination including human decontaminating agents; biocatalysis, novel test techniques suitable for high throughput screening; process improvement and delivery optimisation for biopharmaceuticals and advanced therapy medicinal products.
Gene therapy; viral vectors
Construction of databases on genomes; protein sequences; modelling complex biological processes; including systems biology; developing personalised genomics.
Application of the tools and processes of nano/microfabrication to build devices for studying biosystems and applications in drug delivery, diagnostics, manufacturing.


